Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Stock Short Interest Report for September

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 39,624 shares, a decrease of 64.6% from the September 15th total of 111,907 shares. Based on an average trading volume of 168,560 shares, the days-to-cover ratio is presently 0.2 days.

Ono Pharmaceutical Stock Performance

Shares of OPHLY traded up $0.05 during trading hours on Tuesday, hitting $4.77. 13,163 shares of the company were exchanged, compared to its average volume of 36,043. Ono Pharmaceutical has a fifty-two week low of $3.81 and a fifty-two week high of $5.75. The firm’s fifty day moving average is $5.03 and its 200 day moving average is $4.98.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd. is a Japan-based, research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its activities focus primarily on areas of high unmet medical need, including oncology, immunology, neurology and other specialty-care fields.

The company’s best-known product is Opdivo (nivolumab), an immune checkpoint inhibitor used in the treatment of multiple cancers. Ono has also developed or commercialized other specialty medicines, including treatments for cancer and immune-related conditions, through internal research and collaborations with pharmaceutical companies in Japan and overseas.

Ono Pharmaceutical traces its origins to 1717, when it began as a drug wholesaler in Osaka, and was incorporated in its modern corporate form in 1947.